Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06472297 · ClinicalTrials.gov registry record · NA

Continuous Glucose Monitoring in Prediabetes

A NA study of Pre Diabetes, sponsored by University of Southern California.

Completed
Registry status
NA
Development phase
23
Enrollment target
1
Study location

NCT06472297 is a NA study of Pre Diabetes that has completed, run by University of Southern California. The registered enrollment target is 23 participants, below the 729-participant average among 59 other Pre Diabetes trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06472297, a NA study of Pre Diabetes, has completed, sponsored by University of Southern California.

COMPLETED
Registry status
NA
Development phase
23 participants
Enrollment target
1
Study location

Study Summary

The objective of this project is to develop a behavioral intervention that combines wearable continuous glucose monitoring (CGM) with smartphone feedback and educational video clips generated by artificial intelligence (AI) software to improve glycemic control among individuals with pre-diabetes. The goal is to prevent transition to type 2 diabetes.

Conditions Studied

Interventions

  • DEVICE The continuous glucose monitoring system

Study Locations (1)

California

  • Southern California Center for Latino Health SCCLH - Los Angeles

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2024-06-01
Est. Completion 2024-09-30
Phase NA

Sponsor

University of Southern California

617 total trials

What the Registry Record Tells You About NCT06472297

The ClinicalTrials.gov registry entry for NCT06472297 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 729-participant average among 59 other Pre Diabetes trials with a reported enrollment target (97% lower). The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pre Diabetes appearing as the primary indexed condition, and to 1 intervention - of which The continuous glucose monitoring system is the first listed.

NCT06472297 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06472297 about?

NCT06472297 is a clinical study titled "Continuous Glucose Monitoring in Prediabetes". The objective of this project is to develop a behavioral intervention that combines wearable continuous glucose monitoring (CGM) with smartphone feedback and educational video clips generated by artificial intelligence (AI) software to improve glycemic control among individuals with pre-diabetes. Th...

What is the current status of trial NCT06472297?

This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2024-06-01. Estimated completion is 2024-09-30.

What conditions does trial NCT06472297 study?

This clinical trial studies the following conditions: Pre Diabetes.

What interventions are being tested in trial NCT06472297?

The interventions under investigation include: The continuous glucose monitoring system (DEVICE).

Who is sponsoring clinical trial NCT06472297?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06472297 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pre Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.